These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
264 related items for PubMed ID: 20133281
1. Biopsy-proven resolution of renal light-chain deposition disease after autologous stem cell transplantation. Petrakis I, Stylianou K, Mavroeidi V, Vardaki E, Stratigis S, Stratakis S, Xylouri I, Perakis C, Petraki C, Nakopoulou L, Daphnis E. Nephrol Dial Transplant; 2010 Jun; 25(6):2020-3. PubMed ID: 20133281 [Abstract] [Full Text] [Related]
2. Long-term outcome of autologous stem cell transplantation in light chain deposition disease. Lorenz EC, Gertz MA, Fervenza FC, Dispenzieri A, Lacy MQ, Hayman SR, Gastineau DA, Leung N. Nephrol Dial Transplant; 2008 Jun; 23(6):2052-7. PubMed ID: 18178602 [Abstract] [Full Text] [Related]
3. [Complete remission of nephrotic syndrome and improvement of renal function in a patient with light chain deposition disease following high dose chemotherapy with transplantation of autologous haematopoietic stem cells. A case study and review of literature]. Adam Z, Krejcí M, Pour L, Stepánková S, Cermáková Z, Voska L, Teplan V, Krivanová A, Hájek R, Mayer J. Vnitr Lek; 2009 Nov; 55(11):1089-96. PubMed ID: 20017442 [Abstract] [Full Text] [Related]
4. Clinical and molecular characteristics of patients with non-amyloid light chain deposition disorders, and outcome following treatment with high-dose melphalan and autologous stem cell transplantation. Weichman K, Dember LM, Prokaeva T, Wright DG, Quillen K, Rosenzweig M, Skinner M, Seldin DC, Sanchorawala V. Bone Marrow Transplant; 2006 Sep; 38(5):339-43. PubMed ID: 16862166 [Abstract] [Full Text] [Related]
5. Renal monoclonal immunoglobulin deposition disease: a report of 64 patients from a single institution. Nasr SH, Valeri AM, Cornell LD, Fidler ME, Sethi S, D'Agati VD, Leung N. Clin J Am Soc Nephrol; 2012 Feb; 7(2):231-9. PubMed ID: 22156754 [Abstract] [Full Text] [Related]
6. Progressive renal light chain amyloidosis with the absence of detectable free monoclonal light chains after an autologous hematopoietic stem cell transplant for amyloid light chain amyloidosis. Roth RM, Benson D, Hebert LA, Bissell MG, Satoskar AA, Nadasdy T, Brodsky SV. Arch Pathol Lab Med; 2013 Sep; 137(9):1304-8. PubMed ID: 23991744 [Abstract] [Full Text] [Related]
7. Resolution of mesangial light chain deposits 3 years after high-dose melphalan with autologous peripheral blood stem cell transplantation. Harada K, Akai Y, Sakan H, Yamaguchi Y, Nakatani K, Iwano M, Saito Y. Clin Nephrol; 2010 Nov; 74(5):384-8. PubMed ID: 20979947 [Abstract] [Full Text] [Related]
8. Severity of baseline proteinuria predicts renal response in immunoglobulin light chain-associated amyloidosis after autologous stem cell transplantation. Leung N, Dispenzieri A, Lacy MQ, Kumar SK, Hayman SR, Fervenza FC, Cha SS, Gertz MA. Clin J Am Soc Nephrol; 2007 May; 2(3):440-4. PubMed ID: 17699449 [Abstract] [Full Text] [Related]
9. [Light chain deposition disease. Experience in our environment]. Martín Herrera C, Suñer Poblet M, Cabrera R, Díaz Pedrero M, Fernández Alonso J. Nefrologia; 2008 May; 28(5):539-42. PubMed ID: 18816213 [Abstract] [Full Text] [Related]
10. Pulmonary manifestations of light chain deposition disease. Rho L, Qiu L, Strauchen JA, Gordon RE, Teirstein AS. Respirology; 2009 Jul; 14(5):767-70. PubMed ID: 19659654 [Abstract] [Full Text] [Related]
11. [Kidney involvement in light-chain deposition disease]. Merta M, Rysavá R, Zabka J, Stejskalová A, Vernerová Z, Haber J, Spicka I, Tesar V, Klener P. Sb Lek; 2002 Jul; 103(3):397-403. PubMed ID: 12688183 [Abstract] [Full Text] [Related]
13. Recurrence of light chain deposit disease after renal allograft transplantation: potential role of rituximab? Kuypers DR, Lerut E, Claes K, Evenepoel P, Vanrenterghem Y. Transpl Int; 2007 Apr; 20(4):381-5. PubMed ID: 17326779 [Abstract] [Full Text] [Related]
14. Immunoglobulin light (heavy)-chain deposition disease: from molecular medicine to pathophysiology-driven therapy. Ronco P, Plaisier E, Mougenot B, Aucouturier P. Clin J Am Soc Nephrol; 2006 Nov; 1(6):1342-50. PubMed ID: 17699367 [Abstract] [Full Text] [Related]
15. Reversal of dialysis-dependent renal failure in light-chain deposition disease by autologous peripheral blood stem cell transplantation. Firkin F, Hill PA, Dwyer K, Gock H. Am J Kidney Dis; 2004 Sep; 44(3):551-5. PubMed ID: 15332228 [Abstract] [Full Text] [Related]
16. High-dose melphalan with autologous stem cell transplantation after VAD induction chemotherapy for treatment of amyloid light chain amyloidosis: a single centre prospective phase II study. Perz JB, Schonland SO, Hundemer M, Kristen AV, Dengler TJ, Zeier M, Linke RP, Ho AD, Goldschmidt H. Br J Haematol; 2004 Dec; 127(5):543-51. PubMed ID: 15566357 [Abstract] [Full Text] [Related]
17. Bortezomib successfully reverses early recurrence of light-chain deposition disease in a renal allograft: a case report. Kaposztas Z, Kahan BD, Katz SM, Van Buren CT, Cherem L. Transplant Proc; 2009 Dec; 41(10):4407-10. PubMed ID: 20005409 [Abstract] [Full Text] [Related]
18. Light chain deposition disease without glomerular proteinuria: a diagnostic challenge for the nephrologist. Sicard A, Karras A, Goujon JM, Sirac C, Bender S, Labatut D, Callard P, Sarkozy C, Essig M, Vanhille P, Provot F, Nony A, Nochy D, Ronco P, Bridoux F, Touchard G. Nephrol Dial Transplant; 2014 Oct; 29(10):1894-902. PubMed ID: 24619059 [Abstract] [Full Text] [Related]
19. Spectrum of glomerular and tubulointerstitial renal lesions associated with monotypical immunoglobulin light chain deposition. Sanders PW, Herrera GA, Kirk KA, Old CW, Galla JH. Lab Invest; 1991 Apr; 64(4):527-37. PubMed ID: 1901926 [Abstract] [Full Text] [Related]
20. Kidney and liver involvement in monoclonal light chain disorders. Pozzi C, Locatelli F. Semin Nephrol; 2002 Jul; 22(4):319-30. PubMed ID: 12118397 [Abstract] [Full Text] [Related] Page: [Next] [New Search]